Core Laboratories (CLB) FCF Payout Ratio (2022 - 2026)

Core Laboratories' FCF Payout Ratio history runs 5 years deep, the most recent figure standing at 0.89 for Q1 2026.

• On a quarterly basis, FCF Payout Ratio rose 785.95% year-over-year to 0.89 in Q1 2026; TTM through Mar 2026 was 0.09, a 160.25% increase from a year earlier, with the FY2025 full-year figure at 0.07, up 111.11% from the prior year.
• FCF Payout Ratio improved to 0.89 in Q1 2026 per CLB's latest filing, from 0.21 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 0.89 in Q1 2026 and bottomed at 0.21 in Q4 2025.
• The 5-year median for FCF Payout Ratio is 0.04 (2023), against an average of 0.07.
• Across the five-year window, FCF Payout Ratio plunged 1004.06% in 2025 and surged 785.95% in 2026, its largest moves.
• Year by year, FCF Payout Ratio stood at 0.13 in 2022, then tumbled by 62.26% to 0.05 in 2023, then slumped by 51.64% to 0.02 in 2024, then plunged by 1004.06% to 0.21 in 2025, then jumped by 530.94% to 0.89 in 2026.
• Per Business Quant, the three latest CLB FCF Payout Ratio figures stand at 0.89 (Q1 2026), 0.21 (Q4 2025), and 0.06 (Q3 2025).